Can AI improve cancer care in remote areas? 3 questions with Dr. Andrew Norden of IBM Watson Health

(By Jessica Kim Cohen for Becker’s Hospital Review)

IBM has rolled out its oncology-focused clinical decision support platform in more than 55 countries in Asia, North America, South America, Europe and Australia since striking an agreement to develop the technology with New York City-based Memorial Sloan Kettering Cancer Center in 2012. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.